This week, the Maine Senate approved a bill allowing adults over the age of 21 to access medical psilocybin, but the House of Representatives killed itreported Marijuana Moment.
Senator Donna Bailey(D)’s bill would have allowed adults 21 and older, with the recommendation of a physician, to have access psilocybin, but did not specify eligibility requirements. The proposal would also have required regulators to create a “psilocybin service facilitator license”, and the Maine Psilocybin Advisory Board would have been established.
The Senate passed the amended measure last Tuesday with a 20-13 vote, but the House did not follow suit and the bill was killed for session. However, Bailey said she plans to relaunch the project next year or put the issue on the ballot for voters to decide..
“I am grateful to my colleagues in the Senate for recognizing the urgent need for psilocybin therapy to be legally available to our veterans and others with PTSD, those struggling with substance use disorders and those who need end-of-life palliative care,” commented the bill’s sponsor. “I’m disappointed the House voted against helping people who may benefit from the ‘reset’ value shown in numerous studies over many years.”
Prior to the body’s vote, Bailey stood in front of the Senate and said that “we owe it to survivors to keep an open mind and explore all possible ways to ease their pain and help them live full and satisfying lives following their traumatic experiences.” She went on to highlight the therapeutic potential of the drug and the possible benefits it could bring to patients in distress.
Rep. Michele Meyer (D), chairman of the health and human services legislative committee, where the bill was previously defeated, did not entirely dismiss the possibility that psilocybin is a viable drug. Instead, she said her concern is that the substance has not yet been approved by the FDA.
“This is a breakthrough therapy and it shows promise, but the science isn’t there yet,” she explained.
Photo: Courtesy of Marco Allegretti at Unsplash.